1 – 35 of 35
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Glucocorticoid treatment in SLE is associated with infections, comorbidities and mortality—a national cohort study
(
- Contribution to journal › Article
- 2022
-
Mark
Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus
(
- Contribution to journal › Article
- 2021
-
Mark
Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus
(
- Contribution to journal › Article
-
Mark
De novo lupus nephritis during treatment with belimumab
(
- Contribution to journal › Article
- 2020
-
Mark
Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus
(
- Contribution to journal › Article
- 2019
-
Mark
Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use
(
- Contribution to journal › Article
-
Mark
Functional connectivity changes in core resting state networks are associated with cognitive performance in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2018
-
Mark
Functional Connectivity Changes in Systemic Lupus Erythematosus : A Resting-State Study
(
- Contribution to journal › Article
-
Mark
Variation in pain related to systemic lupus erythematosus (SLE) : a 7-year follow-up study
(
- Contribution to journal › Article
- 2017
-
Mark
The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients
(
- Contribution to journal › Article
-
Mark
A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus
(
- Contribution to journal › Article
- 2016
-
Mark
Biomarker Discovery in Autoimmune Diseases using Antibody Microarrays : Targeting Systemic Lupus Erythematosus
2016)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus : A preliminary study
(
- Contribution to journal › Article
-
Mark
MR Diffusion Tractography to Identify and Characterize Microstructural White Matter Tract Changes in Systemic Lupus Erythematosus Patients
(
- Contribution to journal › Article
- 2013
-
Mark
Reduced Insular Glutamine and N-Acetylaspartate in Systemic Lupus Erythematosus: A Single-Voxel H-1-MR Spectroscopy Study
(
- Contribution to journal › Article
- 2012
-
Mark
Perfusion-weighted MR Imaging in Cerebral Lupus Erythematosus
(
- Contribution to journal › Article
- 2011
-
Mark
Molecular basis of hereditary C1q deficiency-revisited: identification of several novel disease-causing mutations
(
- Contribution to journal › Article
- 2010
-
Mark
Apoptosis of Peripheral Blood Leukocytes in Systemic Lupus Erythematosus: Studies on Serum Induction and Complement-Dependent Clearance Mechanisms
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Systemic Lupus Erythematosus, with focus on vascular wall changes, cardiac risk-factor awareness and cardiovascular events
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Molecular serum portraits - A step towards personalized medicine
2010)(
- Thesis › Doctoral thesis (compilation)
- 2007
-
Mark
Lung cancer in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Gene-environment interactions in the aetiology of systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed: A study with a questionnaire.
(
- Contribution to journal › Article
-
Mark
C1q deficiency in an Inuit family: Identification of a new class of C1q disease-causing mutations
(
- Contribution to journal › Article
-
Mark
Complement deficiencies and systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.
(
- Contribution to journal › Article
-
Mark
Studies on hereditary C2 deficiency: Frequent occurrence of severe infections, atherosclerosis and rheumatological manifestations
2007) In 2007:149(
- Thesis › Doctoral thesis (compilation)
- 2006
-
Mark
Increased aortic pulse wave velocity in middle aged women with systemic lupus erythematosus
(
- Contribution to journal › Article
- 2005
-
Mark
Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus
(
- Contribution to journal › Article
- 2004
-
Mark
ACR classification criteria for systemic lupus erythematosus: complement components
(
- Contribution to journal › Article
- 2002
-
Mark
The complement systemin systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
On the etiology and pathogenesis of systemic lupus erythematosus with special reference to environmental factors
2002)(
- Thesis › Doctoral thesis (compilation)
- 2000
-
Mark
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies
(
- Contribution to journal › Article
- 1999
-
Mark
DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q
(
- Contribution to journal › Article
-
Mark
Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus
(
- Contribution to journal › Article